Healthcare Sector

ABBV

Market Tracker

  • ABBV (Selected)

    AbbVie Inc.

ABBV Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

ABBV Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

ABBV Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

ABBV Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
06/20/2025 PUT $150.00 3,588 +1,000 +38.64%
08/15/2025 PUT $160.00 392 +326 +493.94%
06/20/2025 CALL $230.00 1,150 +321 +38.72%
06/20/2025 PUT $105.00 346 +309 +835.14%
06/20/2025 PUT $120.00 807 +270 +50.28%
01/17/2025 CALL $182.50 824 +258 +45.58%
06/20/2025 PUT $160.00 1,158 -33 -2.77%
01/31/2025 PUT $175.00 1,651 -35 -2.08%
03/21/2025 PUT $175.00 1,465 -36 -2.40%
01/31/2025 CALL $180.00 245 -45 -15.52%
01/17/2025 PUT $165.00 3,248 -81 -2.43%
03/21/2025 PUT $170.00 3,081 -118 -3.69%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

ABBV Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 53.76M 7.26B
Vanguard 500 Index Fund 2.32% 40.88M 5.52B
Fidelity 500 Index Fund 1.10% 19.39M 2.62B
SPDR S&P 500 ETF Trust 1.09% 19.15M 2.58B
American Mutual Fund Inc 1.00% 17.6M 2.38B
iShares Core S&P 500 ETF 0.89% 15.78M 2.13B
Vanguard Index-Value Index Fund 0.87% 15.28M 2.06B
Capital Income Builder, Inc. 0.84% 14.87M 2.01B
Select Sector SPDR Fund-Health Care 0.81% 14.36M 1.94B
Washington Mutual Investors Fund 0.75% 13.22M 1.78B

ABBV News

  • NUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries

    01/09 11:53 am

    GlobeNewswire Inc.

    Read more
  • Alzheimer's Disease Diagnostics Research Report 2024-2034: Global Market to Reach $27.87 Billion - Focus on Cost-Effective Alzheimer's Diagnostics Gaining Momentum

    01/09 11:48 am

    GlobeNewswire Inc.

    Read more
  • The Smartest Dividend Stocks to Buy With $500 Right Now

    01/06 06:45 am

    The Motley Fool

    Read more
  • 2 No-Brainer Dividend Stocks to Buy With $250 in 2025

    01/06 05:17 am

    The Motley Fool

    Read more
  • Time to Dump or Double Up on SCHD?

    01/04 09:35 am

    The Motley Fool

    Read more
  • 3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

    01/04 06:19 am

    The Motley Fool

    Read more
  • Bioconjugation Market Global Forecast to 2029 with Danaher, Lonza, Thermo Fisher Scientific, Merck, AbbVie, WuXi Biologics, and Sartorius Leading

    01/02 08:52 am

    GlobeNewswire Inc.

    Read more
  • The Smartest Dividend Stocks to Buy With $1,000 Right Now

    12/26 06:35 am

    The Motley Fool

    Read more
  • Pharmaceuticals & Medicine Manufacturing Market Set to Surge at 8.9% CAGR, to Reach US$ 2,516.46 Million by 2034 | Fact.MR Report

    12/24 07:30 am

    GlobeNewswire Inc.

    Read more
  • Is AbbVie Stock a Buy?

    12/23 09:30 am

    The Motley Fool

    Read more
  • 2 Excellent Dividend Stocks to Buy on the Dip

    12/23 05:32 am

    The Motley Fool

    Read more
  • 2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

    12/22 07:50 am

    The Motley Fool

    Read more
  • 3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

    12/21 07:48 am

    The Motley Fool

    Read more
  • Is AbbVie Ready for a Bullish Turn?

    12/17 03:15 am

    Investing.com

    Read more
  • Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

    12/15 06:35 am

    The Motley Fool

    Read more
  • Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

    12/09 01:00 pm

    GlobeNewswire Inc.

    Read more
  • AbbVie's Early Parkinson's Candidate Hits Primary Goal In Pivotal Late-Stage Study

    12/09 12:16 pm

    Benzinga

    Read more
  • Cancer Monoclonal Antibodies Market to Grow at a 18.4% CAGR through 2031 | SkyQuest Technology

    12/09 08:10 am

    Benzinga

    Read more
  • Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma

    12/08 01:30 pm

    GlobeNewswire Inc.

    Read more
  • Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

    12/07 08:12 pm

    GlobeNewswire Inc.

    Read more
  • 3 High-Dividend, High-Growth Stocks to Gift Your Portfolio This Holiday Season

    12/04 10:30 am

    Investing.com

    Read more
  • 3 High-Yield Dividend Growth Stocks to Buy in December and Hold for a Decade or Longer

    12/03 05:24 am

    The Motley Fool

    Read more
  • 3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later

    12/01 06:52 am

    The Motley Fool

    Read more
  • Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

    11/30 06:41 am

    The Motley Fool

    Read more
  • Proton Pump Inhibitors Market to Surpass Valuation of USD 7.35 Billion by 2031 | SkyQuest Technology

    11/25 05:51 am

    GlobeNewswire Inc.

    Read more
  • The Stock Market Is Soaring but These 2 Stocks Are Still Dirt Cheap Buys

    11/23 10:17 am

    The Motley Fool

    Read more
  • 3 Dividend Stocks That Are Screaming Buys in November

    11/23 08:20 am

    The Motley Fool

    Read more
  • Protein Therapeutics Market Size to be Worth USD 549.4 billion by 2031, at a CAGR of 6.3% | Transparency Market Research, Inc.

    11/15 07:00 am

    GlobeNewswire Inc.

    Read more
  • Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock

    11/15 06:50 am

    The Motley Fool

    Read more
  • 2 Dividend Stocks to Buy Hand Over Fist in November

    11/14 11:15 am

    The Motley Fool

    Read more
  • AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio

    11/12 02:52 pm

    Benzinga

    Read more
  • AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated

    11/11 01:51 pm

    Benzinga

    Read more
  • Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR – S&S Insider

    11/11 12:45 pm

    GlobeNewswire Inc.

    Read more
  • AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges

    11/11 11:27 am

    Benzinga

    Read more
  • 3 Spectacular High-Yield Dividend Stocks to Buy in November

    11/10 10:30 am

    The Motley Fool

    Read more
  • My Favorite Dividend King to Buy in November

    11/09 06:48 am

    The Motley Fool

    Read more
  • Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks

    11/08 03:35 pm

    Benzinga

    Read more
  • The Physician-Patient Alliance for Health & Safety Expands Board of Advisors with Five Healthcare Industry Leaders, Enhancing Commitment to Patient Safety and Innovation

    11/06 11:00 am

    GlobeNewswire Inc.

    Read more
  • 5 Dividend Stocks to Double Up on Right Now -- Plus Some Dividend ETFs

    10/31 05:30 am

    The Motley Fool

    Read more
  • Medical Spa Market to hit USD 55.3 billion by 2032, says Global Market Insights Inc.

    10/29 04:30 am

    GlobeNewswire Inc.

    Read more
  • 2023 Vision Health Report: Post Pandemic Recovery-Challenges Remain

    10/28 10:56 am

    GlobeNewswire Inc.

    Read more
  • 3 Dividend Growth Stocks You Can Buy and Hold Forever

    10/26 07:30 am

    The Motley Fool

    Read more
  • Beat the Nasdaq With This Cash-Gushing Dividend Stock

    10/23 06:50 am

    The Motley Fool

    Read more
  • 3 Growth Stocks That Could Be Bargain Buys Right Now

    10/18 05:20 am

    The Motley Fool

    Read more
  • FDA Approves AbbVie's Parkinson's Treatment, Medicare Coverage Expected Next Year

    10/17 11:31 am

    Benzinga

    Read more
  • Biopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments

    10/14 10:58 am

    GlobeNewswire Inc.

    Read more
  • Chemotherapy Drugs Market Report 2024: Essential Growth Dynamics and Advancements to 2030

    10/14 10:54 am

    GlobeNewswire Inc.

    Read more
  • 2 Magnificent Dividend Stocks to Buy and Hold Forever

    10/14 09:45 am

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: